I Read The News Today Oh Boy! 13-Mar-2019

Wednesday, Mar 13 2019 by
9

Morning all!

Dignity ( Dignity (LON:DTY) ) – 742p – £371m – PER 10.8

Results For The 12 Months To 28th December 2018 – Revenue down -3%, Underlying PBT down -30% and Underlying EPS fown -33%, the Dividend is flat. Competition and Markets Authority investigation into industry likely to commence this year.

I still don’t see any reason to be “bottom picking” here just yet.

EKF Diagnostic Holdings ( EKF Diagnostics Holdings (LON:EKF) ) – 32p – £145m – PER 23

Results For The 12 Months To End December 2018 – Revenue up 2%, PBT up 280% from £4.3m to £12.2m, Underlying EPS up almost 100% from 58p to 101p (correction 0.58p to 1.01p). Q1 of the new year in-line with management expectations.

I had this down as fairly priced around this level, need to circle back to this and check out the exceptionals here.

Empresaria ( Empresaria (LON:EMR) ) – 68p – £33.3m – PER 5.6

Results For The 12 Months To End December 2018 – Revenue up 5%, Adjusted PBT up 18%, Adjusted Diluted EPS down -3%. The Final Dividend is up 52%, with Net Debt at £17m why not pay some of it off instead!

Still seems reasonable value on a PER <6 but I will remain on the side-lines – Net Debt is a no go for me.

Franchise Brands ( Franchise Brands (LON:FRAN) ) – 68p – £52.7m – PER 18.7

Results For The 12 Months To End December 2018 – Ahead of expectations, Revenue up 43% to £35.5, Adjusted PBT up 36%, Basic Adjusted EPS up 21% and the Total Dividend is up 34%. New year started well, mention of potential acquisitions.

I am still tempted to take a long positon here, if I do not this it will remain on my Watchlist.

Lookers ( Lookers (LON:LOOK) ) – 102p – £397m – PER 7.5

Results For The 12 Months To End December 2018 – Revenue up 4%, Adjusted PBT down -2%, Adjusted EPS down -8.7% and the Total Dividend up 5%. Good start to the new year, in-line with expectations.

Still no change to my Neutral stance here.

Marshall Motor Holdings ( Marshall Motor Holdings (LON:MMH) ) – 158p – £123m – PER 6.7

Results For The 12 Months To End December 2018 – Record results with Revenue and PBT up 1.2%, Basic Underlying EPS is up 1.9%. Dividend up 30%+, FY outlook unchanged.

I said this last time and it's still my view today "I remain wary of the industry and remain Neutral here – Although this would probably be (will probably be) my pick of the options as and when we see some kind of improved sentiment in the industry as a whole (sound management it seems, decent well covered yield and £120m or so of property on the Balance sheet).  Almost talking myself into buying now!".

SafeCharge International ( SafeCharge International (LON:SCH) ) – 297p – £452m – PER 18.5

Results For The 12 Months To End December 2018 – Revenue up 24%, PAT up 4%, Diluted EPS up 3% and the Total Dividend is up 8%. Excellent start to the new year with a strong sales pipeline.

Having sold out here in July (2018) this still looks about fairly priced (at best) to me.

Somero Enterprises ( Somero Enterprises Inc (LON:SOM) ) – 375p – £211m – PER 11.7

Results For The 12 Months To End December 2018 – Record Revenue (+10%) and PBT (+13), Net Cash is up 48% and the Dividend (19c) is up 23% (there's also a Special Dividend which is up 225% (11.7c).

Looks good, looks to have beaten the forecasts I have in my notes. Will be reviewing this with a potential to buy back in again. 

As always, all comment most welcome!


Disclaimer:  

As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. The author may own shares in any companies discussed, all opinions are his/her own & are general/impersonal. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.


Do you like this Post?
Yes
No
9 thumbs up
0 thumbs down
Share this post with friends



Dignity plc is a United Kingdom-based provider of funeral related services in the United Kingdom. The Company operates through three segments: funeral services, crematoria and pre-arranged funeral plans. The Company's funeral services relate to the provision of funerals and ancillary items, such as memorials and floral tributes. The Company's crematoria services relate to cremation services and the sale of memorials and burial plots at the Company operated crematoria and cemeteries. The Company's pre-arranged funeral plans include the sale of funerals in advance to customers wishing to make their own funeral arrangements, and the marketing and administration costs associated with the sales. The Company operates a network of approximately 720 funeral locations throughout the United Kingdom trading under established local trading names. The Company operates approximately 40 crematoria in England and Scotland. The Company's number of active funeral plans is approximately 374,000. more »

LSE Price
697.5p
Change
-1.2%
Mkt Cap (£m)
352.5
P/E (fwd)
10.3
Yield (fwd)
3.5

EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240. more »

LSE Price
30.85p
Change
0.7%
Mkt Cap (£m)
139.2
P/E (fwd)
21.5
Yield (fwd)
n/a

Empresaria Group plc is a United Kingdom-based international specialist staffing company. The Company's principal activity is the provision of staffing and recruitment services. The Company is organized across three regions: UK, Continental Europe and Rest of the World and operates across seven key sectors. The Company targets a balanced and diversified spread of operations across its regions and sectors. The Company also targets professional and specialist job levels where its brands can offer value added services to clients. The Company has three main service lines, temporary recruitment, permanent recruitment and offshore recruitment services. The Company’s offshore recruitment services represents a range of different recruitment services and provides training services in South East Asia. The Company's brands include Alternattiva, Ball and Hoolahan, Become, FastTrack and Greycoat. It has operations in 21 countries. more »

LSE Price
72.5p
Change
 
Mkt Cap (£m)
35.5
P/E (fwd)
5.9
Yield (fwd)
2.9



  Is LON:DTY fundamentally strong or weak? Find out More »


3 Posts on this Thread show/hide all

MrContrarian 13th Mar 1 of 3
3

My morning smallcap tweet: Manx banks 215p for holders.

Manx Telecom (LON:MANX), Staffline (LON:STAF), Franchise Brands (LON:FRAN)

Manx Telecom (MANX) recommended offer 215p (inc. dividend), a 15% premium.
Staffline (STAF) £35m contract wins over 27 months. I hold.
Franchise Brands (FRAN) FY rev up 43% to £35.5m, adj EPS up 21% to 3p, "ahead of expectations". Stockopedia F/C is rev £36m and EPS 2.94p, so in line with that.

| Link | Share
andrea34l 13th Mar 2 of 3
1

Thanks for the heads up Matylda, as usual.

I think you have the eps figures incorrect for EKF Diagnostics Holdings (LON:EKF) as it should read 1.01 vs 0.58, so on this basis the current PER is a whopping 30ish. If you take out the Renalytix gain the EBITDA is up a measly 15% and, with revenue up only 2%, these numbers simply don't stack up with the PER IMHO.

I have consistently said on here that IMHO Marshall Motor Holdings (LON:MMH) are the pick of motor dealers who consistently outperform their peers, something they continue to do. I have traded these shares, and retained a small holding which I am happy to keep, but I wouldn't consider topping up with Brexit uncertainty around this industry.

There are smashing results from Burford Capital (LON:BUR) this morning, with profit up 24%!

I'm glad I withheld from buying SafeCharge International (LON:SCH) as I think there is a lot of froth from the directors, and profits are sluggish compared to revenues.

Will post another update if I see anything else, one I've woken up and digested things... zz

| Link | Share | 1 reply
matylda 13th Mar 3 of 3

In reply to post #457283

Good morning.

Thanks, I have now corrected that and thanks for the commentary, if it wasn't for Brexit Marshall Motor Holdings (LON:MMH) would be tempting.

Blog: Briefed Up
| Link | Share

What's your view on this thread? Log In to Comment Now

You can track all @StockoChat comments via Twitter




Stock Picking Tutorial Centre



Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis